Logo
279hawk_compass
10 days ago
The biggest return in the U.S. market this year came from the cost of moving oil across the ocean.
The Breakwave Tanker Shipping ETF (BWET) has climbed about 3,600% since the start of the year. That makes it the top-performing non-leveraged fund in the country, ahead of every AI and energy trade that grabbed headlines.
BWET now trades near $726 a share, up from under $20 in January. The huge increase traces back to one event that reshaped global shipping, and it carries a warning for anyone tempted to buy in now.
BWET tracks the price of moving oil by sea. It does that by holding short-dated freight futures, which are contracts that lock in the future cost of renting an oil tanker.
About 90% of the fund follows shipping agreements with the biggest tankers on the route from the Middle East to China. Those agreements lift BWET whenever hiring rates increase.

#cost #agreements
279hawk_compass
11 days ago
279hawk_compass
17 days ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Whether you're moving out of town, worried about your bank's future, or just found a better option, you may want to close your bank account.
If so, there are a few important steps you should follow. Here's how to close a bank account and overcome any potential hurdles.
How to close a bank account: General guidelines
How to close a checking account

#disclosure #page
279hawk_compass
20 days ago
President and CFO Andrew Guggenhime reported the disposition of 2,705 shares of Vaxcyte, Inc. (NASDAQ:PCVX), according to a recent SEC Form 4 filing.
Metric
Value
Transaction value
~$165,492

#andrew #NASDAQ #pcvx #metric
279hawk_compass
26 days ago
Nvidia (NVDA) didn't like what it saw in Wall Street estimates for its future revenue growth.
"In addition to having much stronger visibility into next year, the team noted that its decision to provide an out-year outlook was also motivated by the fact that there was a meaningful gap between Street estimates and what Nvidia was seeing internally, which the company believed could have created supply-chain planning challenges for partners," JPMorgan ******* yst Harlan Sur wrote in a note today after his meeting with Nvidia executives.
With Nvidia's stock stuck in neutral for the better part of the summer prior to earnings as investors fretted about peak artificial intelligence growth, the chip darling decided to take one swift measure to silence the naysayers.
The action: serving up a rare long-term outlook that blew everyone on the Street away.
Nvidia said after reporting its fiscal second quarter earnings that it sees 70% revenue growth for fiscal year 2028. This was above ******* yst forecasts for 45% growth. The sales gain would be larger — think in excess of 100% — if not for memory chip shortages, said Nvidia CEO Jensen Huang.

#Growth #estimates #outlook #earnings
279hawk_compass
27 days ago
Snowflake (SNOW) is a cloud data platform company that helps businesses store, ***** yze, and increasingly use their data to power AI applications and workflows. The company had a strong start to fiscal 2027, with product revenue up 34% year-over-year (YoY) to $1.3 billion, while net revenue retention (or NRR) reached 126% in Q1. However, this performance has pushed the stock up 48% year-to-date (YTD), setting a very high bar for Q2, which Snowflake will release on Sept. 2.
Here are three numbers investors should watch in the Q2 report before buying SNOW stock.
Dear Sandisk Stock Fans, Mark Your Calendars for August 31
Dear Palantir Stock Fans, Here's What Maven's Billion-Dollar ARR Means for PLTR
Wu-Tang Clan Member Raekwon Is a Palantir 'OG,' Visiting Headquarters 16 Years After Receiving His Custom PLTR Jacket

#Stock #fans #billion #data
279hawk_compass
27 days ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Why we like it: The Savor card earns the most rewards in bonus categories that are bound to benefit you while traveling abroad. Whether you like to try new restaurants in each city you visit or shop locally to prepare your own meals, you'll get 3% on your food spending. But we especially like how broad the "entertainment" category is, including tickets to tourist attractions, theater shows, amusement parks, and more. This no foreign transaction fee credit card also has no annual fee to offset all the rewards you'll earn.
Why we like it: At just $95 annually, the Chase Sapphire Preferred is one of the best credit cards without foreign transaction fees. It can offer outsized value for international travelers looking for great redemption value, as you can rack up points in various everyday and travel-related categories and then redeem them for travel.
You might choose to transfer points at a 1:1 ratio to one of Chase's 14 partner airline and hotel loyalty programs. Or, you can book travel through Chase using points and get redemption boost on select eligible bookings.
Why we like it: We like the Capital One Venture X as a travel card with premium rewards and benefits for a lower annual fee than some other competitors. If you're looking for a credit card with no foreign transaction fees because you often travel internationally, this card can help you maximize your frequent trips.

#travel #transaction #points
279hawk_compass
1 month ago
Claire McDonough, chief financial officer (CFO) of Rivian Automotive, Inc. (NASDAQ:RIVN), sold 8,023 shares of Class A Common Stock on Aug. 20, 2026, according to an SEC Form 4 filing.
Metric
Value
Shares sold
8,023

#class #common
279hawk_compass
1 month ago
The S&P 500 is up 12.1% in 2026, gaining about 11.1% over six months and 3.1% over three. Moreover, the Nasdaq Composite climbed 12.6% year to date and 14.4% over six months, though it was down nearly 0.4% over three months, while the Dow has risen 10.8%, 7.4%, and 5.9%, respectively. All three indices are running ahead of their late-August 2025 pace. Now, according to TheFly, UBS just reset its S&P 500 outlook for the rest of the year.
However, that doesn't mean that the ride's been easy.
Stocks just wrapped up a losing week as higher Treasury yields, inflation worries, and ongoing tensions around Iran tested a rally that's already carrying lofty valuations. AI stocks wobbled even as corporate earnings remained incredibly strong.
That tension makes UBS's move interesting, as it's not simply chasing an index that has already rallied into double digits.
That said, UBS now sees greater room for stocks to climb through year-end, supported by an unusually robust profit engine.

#august
279hawk_compass
1 month ago
Our ***** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Delivered positive comparable sales of 0.2% as growth in Pro, Online, and Home Services offset macro-driven softness in discretionary DIY spending.
Attributed late-quarter sales pressure to heightened competitive pricing in seasonal categories, which management believes was fueled by competitors utilizing tariff refunds.
Achieved 15.7% online sales growth driven by enhanced visualization tools, expanded marketplace offerings, and the successful rollout of the Mylow AI agent.
Maintained operational discipline through Perpetual Productivity Improvement (PPI) initiatives, enabling the company to absorb elevated fuel and transportation costs.

#driven #delivered
279hawk_compass
1 month ago
Pony.ai reported Tuesday that its overseas robotaxi deployment pipeline has grown to more than 4,000 vehicles, as the Chinese autonomous driving company accelerates its push into international markets.
Those vehicles are already under contract, though when each deployment goes live will depend on permitting, regulatory clearances, and other operational factors, Pony.ai CEO James Peng told ******* ysts on a post-earnings call, according to Reuters. Pony.ai offered no indication of when the full roster of planned international launches would be complete, and gave no figures on how many robotaxis it has actually put on the road outside China.
The total includes a contract with Uber for deployment of more than 2,000 robotaxis in Europe, the company said. Pony.ai did not disclose a breakdown of the remaining commitments across other markets.
Pony.ai announced the expanded Uber partnership last week, which builds on an existing commercial robotaxi service in Zagreb, Croatia, and adds four more European cities. Under the arrangement, Pony.ai contributes its autonomous driving technology and operational expertise, Uber provides its ride-hailing platform, and locally selected providers handle fleet tasks such as maintenance and charging.
Beyond Europe, Pony.ai said it has also advanced robotaxi operations in Luxembourg in collaboration with Bolt and Stellantis, and in Singapore made its robotaxi service available to the general public through ComfortDelGro's Zig app.

#international
279hawk_compass
2 months ago
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J's MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon relationships, and a rapidly expanding da Vinci 5 platform.
The question for investors is not whether OTTAVA can become a viable product, but whether Johnson & Johnson (NYSE:JNJ) can convert its differentiated design and broader surgical portfolio into meaningful market share, and even challenge Intuitive Surgical (ISRG) in the process.
OTTAVA's most compelling feature is its table-integrated architecture. Johnson & Johnson (NYSE:JNJ) stated that the robotic arms are incorporated directly into the operating table, which allows the system to occupy 30% to 50% less ****** e than traditional boom- and cart-mounted systems. The company believes this design could make robotic surgery accessible to operating rooms that previously could not accommodate a larger platform. That gives Johnson & Johnson (NYSE:JNJ) a potentially differentiated selling point among hospitals focused on operating-room capacity and workflow efficiency.
The FDA authorized OTTAVA for multiple upper-abdominal general surgery procedures, including gastric bypass, gastrectomy, cholecystectomy, gastric sleeve surgery, appendectomy, and hiatal hernia repair. Johnson & Johnson (NYSE:JNJ) will commercially launch the OTTAVA system with select customers in the United States to focus on early customer success and simultaneously advance the technology into additional regulatory jurisdictions and indications gradually. In addition, it has an ongoing U.S. clinical trial for OTTAVA in inguinal hernia procedures.
The selective launch is strategically sensible because robotic surgery systems require several factors for their smooth functioning in addition to regulatory authorization, including training for surgeons and operating-room staff, integration of the system into existing workflows, and establishing procedure volumes sufficient to justify the investment. With such a measured rollout, Johnson & Johnson (NYSE:JNJ) has time to collect real-world feedback, improve training, and refine the platform before attempting a broader commercial expansion.

#ottava #operating #market